Can Omega-3s Help Support Kidney Health in IgA Nephropathy? A Review of the Evidence

IgA nephropathy is a kidney disease where inflammation and immune complex buildup can damage kidney filtering units over time. Since standard immune-suppressing treatments often carry side effects and inconsistent results, researchers have been exploring whether omega-3 fatty acids could serve as a gentler add-on approach.

This review pulled together laboratory and clinical findings to look at how omega-3 PUFAs might work at a biological level. Proposed mechanisms include calming certain inflammatory signaling pathways (like NLRP3 and NF-κB), influencing eicosanoid balance, producing specialized molecules that help resolve inflammation, and potentially reducing scarring-related signaling (TGF-β1/Smad3) in kidney tissue.

Despite this promising biological rationale, the authors note that actual clinical trial results are mixed. Some studies suggest omega-3s may modestly reduce protein levels in urine (a marker of kidney stress) in certain patients, but evidence that they meaningfully protect long-term kidney function or prevent kidney failure remains weak and inconsistent.